Correction: Case Report: Complete response and prolonged survival to alectinib in a NSCLC patient with metastases harboring a rare WDR43::ALK structural deletion

There was a mistake in Figure 1 as published. EML4::ALK was erroneously written as ML4::ALK. The corrected Figure 1 appears below.

Figure 1.

Patient clinical management timeline. Months represent de-identified endpoints for each of the events in relation to the initial scan finding.

There was a mistake in Figure 3 as published. Figure 3 was erroneously replaced by a duplicate of Figure 1. The corrected Figure 3 appears below.

Figure 3.

Sagittal view of PET CT demonstrating the FDG avid metastasis in L3 vertebra followed by metabolic resolution and sclerosis of the L3 lesion.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.